REPORTS

Let’s Pullulate and Expand Your Business

Gastroesophageal Reflux Disease (GERD) Market - Global Professional Analysis and Forecast to 2026

Oct 26, 2019  |  161 PAGES  |  REPORT CODE: CMM225189
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Gastroesophageal Reflux Disease (GERD) market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.1% during the forecast period.

This report presents the market size and development trends by detailing the Gastroesophageal Reflux Disease (GERD) market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Gastroesophageal Reflux Disease (GERD) market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Gastroesophageal Reflux Disease (GERD) industry and will help you to build a panoramic view of the industrial development.

Gastroesophageal Reflux Disease (GERD) Market, By Type:

  • Proton Pumps Inhibitors

  • H2 Receptor Antagonists

  • Antacids

  • Prokinetics

  • Others

Gastroesophageal Reflux Disease (GERD) Market, By Application:

  • Hospital

  • Clinic

  • Retail Pharmacies

  • Online Pharmacies

Some of the leading players are as follows:

  • SFJ Pharmaceuticals Group

  • Zeria Pharmaceuticals

  • Daewoong Pharmaceutical

  • AstraZeneca

  • Takeda

  • Vecta Pharmaceuticals

  • GlaxoSmithKline

  • CJ Cheil Jedang

  • Johnson and Johnson

  • Eisai

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Gastroesophageal Reflux Disease (GERD) Market: Technology Type Analysis

  • 4.1 Gastroesophageal Reflux Disease (GERD) Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Gastroesophageal Reflux Disease (GERD) Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Proton Pumps Inhibitors

    • 4.3.2 H2 Receptor Antagonists

    • 4.3.3 Antacids

    • 4.3.4 Prokinetics

    • 4.3.5 Others

5 Gastroesophageal Reflux Disease (GERD) Market: Product Analysis

  • 5.1 Gastroesophageal Reflux Disease (GERD) Product Market Share Analysis, 2018 & 2026

  • 5.2 Gastroesophageal Reflux Disease (GERD) Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Gastroesophageal Reflux Disease (GERD) Market: Application Analysis

  • 6.1 Gastroesophageal Reflux Disease (GERD) Application Market Share Analysis, 2018 & 2026

  • 6.2 Gastroesophageal Reflux Disease (GERD) Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hospital

    • 6.3.2 Clinic

    • 6.3.3 Retail Pharmacies

    • 6.3.4 Online Pharmacies

7 Gastroesophageal Reflux Disease (GERD) Market: Regional Analysis

  • 7.1 Gastroesophageal Reflux Disease (GERD) Regional Market Share Analysis, 2018 & 2026

  • 7.2 Gastroesophageal Reflux Disease (GERD) Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 SFJ Pharmaceuticals Group

    • 9.1.1 SFJ Pharmaceuticals Group Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Zeria Pharmaceuticals

    • 9.2.1 Zeria Pharmaceuticals Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Daewoong Pharmaceutical

    • 9.3.1 Daewoong Pharmaceutical Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 AstraZeneca

    • 9.4.1 AstraZeneca Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Takeda

    • 9.5.1 Takeda Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Vecta Pharmaceuticals

    • 9.6.1 Vecta Pharmaceuticals Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 GlaxoSmithKline

    • 9.7.1 GlaxoSmithKline Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 CJ Cheil Jedang

    • 9.8.1 CJ Cheil Jedang Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Johnson and Johnson

    • 9.9.1 Johnson and Johnson Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Eisai

    • 9.10.1 Eisai Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

 

The List of Tables and Figures (Totals 72 Figures and 133 Tables)

  • Figure Proton Pumps Inhibitors Gastroesophageal Reflux Disease (GERD) market, 2015 - 2026 (USD Million)

  • Figure H2 Receptor Antagonists Gastroesophageal Reflux Disease (GERD) market, 2015 - 2026 (USD Million)

  • Figure Antacids Gastroesophageal Reflux Disease (GERD) market, 2015 - 2026 (USD Million)

  • Figure Prokinetics Gastroesophageal Reflux Disease (GERD) market, 2015 - 2026 (USD Million)

  • Figure Others Gastroesophageal Reflux Disease (GERD) market, 2015 - 2026 (USD Million)

  • Figure Hospital market, 2015 - 2026 (USD Million)

  • Figure Clinic market, 2015 - 2026 (USD Million)

  • Figure Retail Pharmacies market, 2015 - 2026 (USD Million)

  • Figure Online Pharmacies market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Gastroesophageal Reflux Disease (GERD) market, by country, 2015 - 2026 (USD Million)

  • Table North America Gastroesophageal Reflux Disease (GERD) market, by type, 2015 - 2026 (USD Million)

  • Table North America Gastroesophageal Reflux Disease (GERD) market, by product, 2015 - 2026 (USD Million)

  • Table North America Gastroesophageal Reflux Disease (GERD) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Gastroesophageal Reflux Disease (GERD) market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Gastroesophageal Reflux Disease (GERD) market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Gastroesophageal Reflux Disease (GERD) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Gastroesophageal Reflux Disease (GERD) market, by type, 2015 - 2026 (USD Million)

  • Table Canada Gastroesophageal Reflux Disease (GERD) market, by product, 2015 - 2026 (USD Million)

  • Table Canada Gastroesophageal Reflux Disease (GERD) market, by application, 2015 - 2026 (USD Million)

  • Table Europe Gastroesophageal Reflux Disease (GERD) market, by country, 2015 - 2026 (USD Million)

  • Table Europe Gastroesophageal Reflux Disease (GERD) market, by type, 2015 - 2026 (USD Million)

  • Table Europe Gastroesophageal Reflux Disease (GERD) market, by product, 2015 - 2026 (USD Million)

  • Table Europe Gastroesophageal Reflux Disease (GERD) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Gastroesophageal Reflux Disease (GERD) market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Gastroesophageal Reflux Disease (GERD) market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Gastroesophageal Reflux Disease (GERD) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Gastroesophageal Reflux Disease (GERD) market, by type, 2015 - 2026 (USD Million)

  • Table Germany Gastroesophageal Reflux Disease (GERD) market, by product, 2015 - 2026 (USD Million)

  • Table Germany Gastroesophageal Reflux Disease (GERD) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Gastroesophageal Reflux Disease (GERD) market, by type, 2015 - 2026 (USD Million)

  • Table France Gastroesophageal Reflux Disease (GERD) market, by product, 2015 - 2026 (USD Million)

  • Table France Gastroesophageal Reflux Disease (GERD) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Gastroesophageal Reflux Disease (GERD) market, by type, 2015 - 2026 (USD Million)

  • Table Italy Gastroesophageal Reflux Disease (GERD) market, by product, 2015 - 2026 (USD Million)

  • Table Italy Gastroesophageal Reflux Disease (GERD) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Gastroesophageal Reflux Disease (GERD) market, by type, 2015 - 2026 (USD Million)

  • Table Spain Gastroesophageal Reflux Disease (GERD) market, by product, 2015 - 2026 (USD Million)

  • Table Spain Gastroesophageal Reflux Disease (GERD) market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Gastroesophageal Reflux Disease (GERD) market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Gastroesophageal Reflux Disease (GERD) market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Gastroesophageal Reflux Disease (GERD) market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Gastroesophageal Reflux Disease (GERD) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Gastroesophageal Reflux Disease (GERD) market, by type, 2015 - 2026 (USD Million)

  • Table China Gastroesophageal Reflux Disease (GERD) market, by product, 2015 - 2026 (USD Million)

  • Table China Gastroesophageal Reflux Disease (GERD) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Gastroesophageal Reflux Disease (GERD) market, by type, 2015 - 2026 (USD Million)

  • Table Japan Gastroesophageal Reflux Disease (GERD) market, by product, 2015 - 2026 (USD Million)

  • Table Japan Gastroesophageal Reflux Disease (GERD) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Gastroesophageal Reflux Disease (GERD) market, by type, 2015 - 2026 (USD Million)

  • Table India Gastroesophageal Reflux Disease (GERD) market, by product, 2015 - 2026 (USD Million)

  • Table India Gastroesophageal Reflux Disease (GERD) market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Gastroesophageal Reflux Disease (GERD) market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Gastroesophageal Reflux Disease (GERD) market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Gastroesophageal Reflux Disease (GERD) market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Gastroesophageal Reflux Disease (GERD) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Gastroesophageal Reflux Disease (GERD) market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Gastroesophageal Reflux Disease (GERD) market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Gastroesophageal Reflux Disease (GERD) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Gastroesophageal Reflux Disease (GERD) market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Gastroesophageal Reflux Disease (GERD) market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Gastroesophageal Reflux Disease (GERD) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Gastroesophageal Reflux Disease (GERD) market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Gastroesophageal Reflux Disease (GERD) market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Gastroesophageal Reflux Disease (GERD) market, by application, 2015 - 2026 (USD Million)

  • Table MEA Gastroesophageal Reflux Disease (GERD) market, by country, 2015 - 2026 (USD Million)

  • Table MEA Gastroesophageal Reflux Disease (GERD) market, by type, 2015 - 2026 (USD Million)

  • Table MEA Gastroesophageal Reflux Disease (GERD) market, by product, 2015 - 2026 (USD Million)

  • Table MEA Gastroesophageal Reflux Disease (GERD) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Gastroesophageal Reflux Disease (GERD) market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Gastroesophageal Reflux Disease (GERD) market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Gastroesophageal Reflux Disease (GERD) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Gastroesophageal Reflux Disease (GERD) market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Gastroesophageal Reflux Disease (GERD) market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Gastroesophageal Reflux Disease (GERD) market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table SFJ Pharmaceuticals Group Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Zeria Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Daewoong Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Takeda Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Vecta Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table CJ Cheil Jedang Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Johnson and Johnson Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Eisai Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top